AXIOM INVESTORS LLC /DE – Halozyme Therapeutics, Inc. Transaction History
AXIOM INVESTORS LLC /DE portfolio value:
$4.48M
portfolio value
AXIOM INVESTORS LLC /DE quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +30.49% | 26.5K shares | 660K | $39.54 | 113.42K |
| Q2 2022 | share | Increase | +34.70% | 22.39K shares | 1.25M | $44 | 86.92K |
| Q1 2022 | share | Decrease | -21.73% | -17.91K shares | -741K | $39.88 | 64.53K |
| Q4 2021 | share | Decrease | -14.47% | -13.94K shares | -606K | $40.32 | 82.44K |
| Q3 2021 | share | Decrease | -10.28% | -11.04K shares | -958K | $40.68 | 96.39K |
| Q2 2021 | share | Increase | +4.48% | 4.60K shares | 592K | $45.41 | 107.43K |
| Q1 2021 | share | Increase | 0.00% | 102.83K shares | 4.28M | $41.69 | 102.83K |
| Q4 2020 | share | Increase | 0.00% | 130.75K shares | 5.58M | $42.71 | 130.75K |